CB
GILD icon

Chris Bulman’s Gilead Sciences GILD Stock Holding History

Chris Bulman’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Buy
1,923
+360
+23% +$47.4K 0.09% 145
2026
Q1 		$218K Sell
1,563
-114
-7% -$16K 0.1% 137
2025
Q4 		$206K Buy
+1,677
New +$204K 0.09% 142
2025
Q3 		– Sell
-2,092
Closed -$232K – 145
2025
Q2 		$232K Buy
+2,092
New +$223K 0.13% 109
2024
Q3 		– Sell
-1,658
Closed -$114K – 235
2024
Q2 		$114K Buy
+1,658
New +$111K 0.08% 130

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Chris Bulman's GILD Position: Q2 2026 in Review

Chris Bulman increased its Gilead Sciences (GILD) stake by 23% in Q2 2026, buying an estimated $47.4K and bringing the position to 1,923 shares worth $243K. The position accounts for 0.09% of the portfolio, ranked #145.

Chris Bulman first reported a position in GILD in Q2 2024 and has held it in 5 quarters since. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Chris Bulman held 1,923 shares of Gilead Sciences worth $243K as of Q2 2026.
  • Chris Bulman bought 360 Gilead Sciences shares in Q2 2026, an estimated $47.4K.
  • Gilead Sciences made up 0.09% of Chris Bulman's portfolio in Q2 2026, its #145 holding.
  • Chris Bulman first reported a position in Gilead Sciences in Q2 2024 and has held it in 5 quarters since.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Chris Bulman's 13F filing for Q2 2026, filed 22 Jul 2026.